SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000902664-22-005070
Filing Date
2022-12-08
Accepted
2022-12-08 12:42:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 APPLIED GENETIC TECHNOLOGIES CORPORATION p22-2577sc13d.htm SC 13D 99050
2 JOINT FILING AGREEMENT p22-2577exhibit99.htm EX-99.1 7474
  Complete submission text file 0000902664-22-005070.txt   108051
Mailing Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615
Business Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615 386-462-2204
APPLIED GENETIC TECHNOLOGIES CORP (Subject) CIK: 0001273636 (see all company filings)

IRS No.: 593553710 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-88071 | Film No.: 221452008
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 359-7300
Tetragon Financial Management LP (Filed by) CIK: 0001758892 (see all company filings)

IRS No.: 203311552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D